fludarabine phosphate

Poland

Drugs containing this active substance

  • FLUDARA

    The medicinal product is used in the initial treatment of chronic B-cell lymphocytic leukemia and in patients for whom previous treatment of this type of leukemia has not resulted in improvement or has led to disease progression.

    Form: tablets, film-coated

    Active substance Dosage
    fludarabine phosphate 10 mg

    ATC: L01BB05

    Manufacturer: Sanofi Winthrop Industry

  • FLUDARABINE ACCORD

    The medicine is used to treat chronic B-cell lymphocytic leukemia (B-CLL) in patients whose production of healthy blood cells is sufficient, and where the disease is advanced or shows clear progression.

    Form: solution for injection and infusion, concentrate

    Active substance Dosage
    fludarabine phosphate 25 mg/ml

    ATC: L01BB05

    Manufacturer: Accompagny Healthcare Polska Ltd.